Valuation : Ridgeback Resources Inc

Market Cap 181K 156K 147K 134K 250K 17.05M 252K 1.74M 674K 8.72M 678K 663K 28.64M P/E 2016
-1.88x
P/E 2017 -3.96x
Enterprise Value 1.31M 1.13M 1.06M 969K 1.81M 124M 1.82M 12.59M 4.89M 63.2M 4.91M 4.81M 208M EV / Sales 2016
60,329,081x
EV / Sales 2017 18,016,685x
Free-Float
24.19%
Yield 2016 *
-
Yield 2017 -
1 day-92.33%
1 week-94.89%
Current month-94.89%
1 month-78.10%
3 months-92.64%
6 months+820.00%
Current year+820.00%
1 week 0.02
Extreme 0.023
0.36
1 month 0.02
Extreme 0.023
0.95
Current year 0
Extreme 0.0025
5
1 year 0
Extreme 0.0025
5
3 years 0
Extreme 0.0025
5
5 years 0
Extreme 0.0025
12.5
10 years 0
Extreme 0.0025
126.88
Manager TitleAgeSince
Chief Executive Officer - -
General Counsel 77 -
Treasurer 72 -
Director TitleAgeSince
Director/Board Member 77 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-92.33%-94.89%+820.00%-97.58% 243K
-0.38%+3.09%+31.23%+48.06% 124B
-2.79%-5.88%-1.00%+43.18% 87.05B
-2.10%-1.06%-1.39%+55.76% 29.19B
+1.94%-1.71%+34.75%+84.49% 26.58B
+0.13%-4.15%-4.58%-4.70% 21.51B
-2.75%-5.71%+39.48%+228.50% 20.82B
+4.06%+5.18%-4.67%+28.66% 15.85B
-0.65%-2.72%-6.83%-12.43% 12.09B
+1.85%-0.37%+30.99%+74.18% 11.44B
Average -9.52%-1.27%+93.80%+44.81% 34.89B
Weighted average by Cap. -0.40%-0.99%+16.05%+55.65%

Financials

2016 2017
Net sales 0.51 0.44 0.41 0.37 0.7 47.84 0.71 4.87 1.89 24.46 1.9 1.86 80.35 1.04 0.9 0.85 0.77 1.44 98.47 1.45 10.03 3.89 50.34 3.91 3.83 165.37
Net income -15.7M -13.54M -12.76M -11.63M -21.73M -1.48B -21.89M -151M -58.62M -758M -58.96M -57.67M -2.49B -4.25M -3.67M -3.45M -3.15M -5.88M -401M -5.93M -40.88M -15.87M -205M -15.96M -15.61M -674M
Net Debt 355K 306K 289K 263K 491K 33.54M 495K 3.42M 1.33M 17.15M 1.33M 1.3M 56.32M 1.13M 973K 917K 835K 1.56M 107M 1.57M 10.85M 4.21M 54.48M 4.24M 4.14M 179M
Logo Ridgeback Resources Inc
Ridgeback Resources, Inc., formerly Columbine Valley Resources, Inc., is engaged in the business of performing non-invasive ultrasound scans of carotid arteries. The Company is also engaged in producing medical grade reports that evaluate the level of atherosclerotic disease (aka plaque). The report presents detailed information about the presence or absence of atherosclerotic disease.
Employees
7
Date Price Change Volume
01/09/26 $0.3550 -21.11% 100
  1. Stock Market
  2. Stocks
  3. RBRS Stock